参考文献/References:
[1] Ponnatt TS,Lilley CM,Mirza KM.Hemophagocytic lymphohistiocytosis[J].Arch Pathol Lab Med,2022,146(4):507-519.
[2] Henter JI,Samuelsson-Horne A,Arico M,et al.Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation[J].Blood,2002,100(7):2367-2373.
[3] Chahine Z,Jayakrishnan T,Samhouri Y,et al.Haemophagocytic lymphohistiocytosis that spontaneously resolved:A case of EBV[J].BMJ Case Rep,2020,13(11):e235544.
[4] Henter JI,Horne A,Arico M,et al.HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatr Blood Cancer,2007,48(2):124-131.
[5] Ramos-Casals M,Brito-Zeron P,Lopez-Guillermo A,et al.Adult haemophagocytic syndrome[J].Lancet,2014,383(9927):1503-1516.
[6] Chandrakasan S,Filipovich AH.Hemophagocytic lymphohistiocytosis:Advances in patho physiology,diagnosis,and treatment[J].J Pediatr,2013,163(5):1253-1259.
[7] 高伟波,石茂静,宋小静,等.81例成人噬血细胞性淋巴组织细胞增生症临床分析[J].中华血液学杂志,2020,41(3):248-250.
[8] 王旖旎,王 昭,吴 林,等.多中心72例噬血细胞综合征诊疗分析[J].中华血液学杂志,2009,12(6):793-798.
[9] Hutchinson M,Tattersall RS,Manson JJ,et al.Haemophagocytic lymphohisticytosis-an underrecognized hyperinflammatory syndrome[J].Rheumatology(Oxford),2019,58(Suppl 6):23-30.
[10] 黄文秋,王旖旎,王晶石.192例成人噬血细胞淋巴组织细胞增生症患者的临床分析[J].中华血液学杂志,2014,35(9):796-801.
[11] Fardet L,Galicier L,Lambotte O,et al.Development and validation of the HScore,a score for the diagnosis of reactive hemophagocytic syndrome[J].Arthritis Rheumatol,2014,66(9):2613-2620.
[12] Dimopoulos G,Mast Q,Markou N,et al.Favorable anakinra responses in severe COVID-19 patients with secondary hemophagocytic lymphohistiocytosis[J].Cell Host Microbe,2020,28(1):117-123.
[13] Clark KEN,Nevin WD,Mahungu T,et al.Assessment of the hemophagocytic lymphohistiocytosis hscore in patients with coronavirus disease 2019[J].Clin Infect Dis,2021,73(9):e3110-e3112.
[14] Schram AM,Comstock P,Campo M,et al.Haemophagocytic lymphohistiocytosis in adults:A multicentre case series over 7 years[J].Br J Haematol,2016,172(3):412-419.
[15] 肖 瑾,孙 玲,桑丽娜,等.噬血细胞综合征102例临床观察及预后分析[J].白血病?淋巴瘤,2015,24(5):295-297.
[16] Yoon JH,Park SS,Jeon YW,et al.Treatment outcomes and prognostic factors in adult patients with secondary hemophagocytic lymphohistiocytosis not associated with malignancy[J].Haematologica,2019,104(2):269-276.
[17] Esteban YM,Jong JLO,Tesher MS.An overview of hemophagocytic lymphohistiocytosis[J].Pediatr Ann,2017,46(8):309-313.
[18] Kim WY,Montes-Mojarro IA,Fend F,et al.Epstein-barr virus-associated T and NK-cell lymphoproliferative diseases[J].Front Pediatr,2019,7:71.
[19] 李亚绒,庞菊萍.儿童EB病毒相关性噬血细胞综合征11例临床分析[J].陕西医学杂志,2008,37(9):1151-1153.
[20] 李亚绒,刘小乖,王小燕.儿童急性细菌性痢疾并发噬血细胞综合征1例报告[J].陕西医学杂志,2009,38(1):127.
相似文献/References:
[1]高 燕,杨 红,刘淑娟,等.线粒体动态蛋白在卵巢癌中的表达及临床意义[J].陕西医学杂志,2021,50(12):1589.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.031]
GAO Yan,YANG Hong,LIU Shujuan,et al.Expression and clinical significance of mitochondrial dynamic protein of 51 kDa in ovarian cancer[J].,2021,50(3):1589.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.031]
[2]张军艳,谷 俊.程序性死亡配体1在肺癌组织中的表达及其与患者病理特征和疾病预后相关性研究[J].陕西医学杂志,2022,51(7):894.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.031]
ZHANG Junyan,GU Jun.Expression of programmed death ligand 1 in lung cancer tissues and its correlation with pathological characteristics and prognosis[J].,2022,51(3):894.[doi:DOI:10.3969/j.issn.1000-7377.2022.07.031]
[3]王忠瑜,季艳霞,赵艳争,等.环状RNA ciRS-7在结直肠癌中的表达变化及其与患者临床病理特征和预后关系研究[J].陕西医学杂志,2024,(3):412.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.027]
WANG Zhongyu,JI Yanxia,ZHAO Yanzheng,et al.Expression change of circular RNA ciRS-7 in colorectal cancer and its relationship with clinicopathological features and prognosis of patients[J].,2024,(3):412.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.027]
[4]刘玉锋,薛芳芳.卵巢癌患者造血前B细胞白血病转录因子相互作用蛋白表达和术前中性粒细胞与淋巴细胞比值水平及其临床检测价值[J].陕西医学杂志,2024,(5):662.[doi:DOI:10.3969/j.issn.1000-7377.2024.05.019]